These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7964545)

  • 1. Fibrinogen: a new major risk factor for cardiovascular disease. A review of the literature.
    de la Serna G
    J Fam Pract; 1994 Nov; 39(5):468-77. PubMed ID: 7964545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen and factor VII as risk factors in vascular disease.
    Hultin MB
    Prog Hemost Thromb; 1991; 10():215-41. PubMed ID: 2008532
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinogen as a cardiovascular risk factor--marker or causal factor?].
    Halvorsen S
    Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2829-32. PubMed ID: 10494205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrinogen as a cardiovascular risk factor].
    Giannasi G; Ferrari S; Galetta F
    Minerva Cardioangiol; 1995 May; 43(5):169-75. PubMed ID: 7478039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinogen: cardiovascular risk factor].
    Espinosa RA;
    Invest Clin; 2002 Dec; 43(4):291-301. PubMed ID: 12521001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic factors and risk of cardiovascular disease in women. An overview.
    Meilahn EN
    Arch Pathol Lab Med; 1992 Dec; 116(12):1313-7. PubMed ID: 1456877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.
    Ernst E
    Eur Heart J; 1993 Dec; 14 Suppl K():82-7. PubMed ID: 8131795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma fibrinogen and cardiovascular disease].
    Møller LF; Jespersen J; Kristensen TS
    Ugeskr Laeger; 1991 Aug; 153(34):2343-5. PubMed ID: 1897044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study.
    Palmieri V; Celentano A; Roman MJ; de Simone G; Best L; Lewis MR; Robbins DC; Fabsitz RR; Howard BV; Devereux RB;
    Am Heart J; 2003 Mar; 145(3):467-74. PubMed ID: 12660670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen and cardiovascular disorders.
    Lip GY
    QJM; 1995 Mar; 88(3):155-65. PubMed ID: 7767665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrinogen: a "new" cardiovascular risk factor].
    Ernst E
    Wien Med Wochenschr; 1991; 141(17):375-82. PubMed ID: 1771915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to secondhand smoke and biomarkers of cardiovascular disease risk in never-smoking adults.
    Venn A; Britton J
    Circulation; 2007 Feb; 115(8):990-5. PubMed ID: 17296856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease.
    Hansen AS; Marckmann P; Dragsted LO; Finné Nielsen IL; Nielsen SE; Grønbaek M
    Eur J Clin Nutr; 2005 Mar; 59(3):449-55. PubMed ID: 15674304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent progress in the "fibrinogen hypothesis"].
    Lefebvre P; Ledent T; Ducobu J
    Rev Med Brux; 2003 Apr; 24(2):82-7. PubMed ID: 12806874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.
    Walldius G; Jungner I
    J Intern Med; 2006 May; 259(5):493-519. PubMed ID: 16629855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinogen. Cardiovascular risk factor or marker?].
    Canseco-Avila LM; Jerjes-Sánchez C; Ortiz-López R; Rojas-Martínez A; Guzmán-Ramírez D
    Arch Cardiol Mex; 2006; 76 Suppl 4():S158-72. PubMed ID: 17469344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data.
    Lonn EM; Yusuf S
    Can J Cardiol; 1997 Oct; 13(10):957-65. PubMed ID: 9374952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    Sinning JM; Bickel C; Messow CM; Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Lackner KJ; Tiret L; Münzel T; Blankenberg S;
    Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.